Flavonoids derived from Anemarrhenae Rhizoma ameliorate inflammation of benign prostatic hyperplasia via modulating COX/LOX pathways

J Ethnopharmacol. 2022 Feb 10:284:114740. doi: 10.1016/j.jep.2021.114740. Epub 2021 Nov 2.

Abstract

Ethnopharmacological relevance: Flavonoids are the main components of the traditional Chinese medicine Anemarrhenae Rhizoma (dried rhizome of Anemarrhena asphodeloides Bge.), which has been reported to possess activity against inflammation and tumor.

Aim of study: Regulation of the arachidonic acid (AA) cascade through cyclooxygenase (COX) and lipoxygenase (LOX) represent the two major pathways to treat inflammatory of benign prostatic hyperplasia (BPH). In this study, Anemarrhenae Rhizoma flavonoids and its main compounds (mangiferin, neomangiferin and isomangiferin) were investigated for effects on AA metabolism.

Methods: Ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) was used to monitor AA metabolites in BPH rats and in PC-3 cells. COX-2 and 5-LOX protein and mRNA levels were measured by Western blot and qPCR, respectively, along with histopathological assessment of prostate tissues.

Results: Treatment with flavonoids significantly ameliorated BPH-associated prostate inflammation and inhibited the expression of COX-2 and 5-LOX at the protein and mRNA levels. Quantitative metabolomic analysis of blood plasma showed flavonoids treatment decreased AA levels and its metabolites associated with the COX and LOX pathways. Further exploration of the flavonoid compounds mangiferin, neomangiferin and isomangiferin showed they inhibited AA metabolism to varying degrees in PC-3 cell cultures.

Conclusion: Anemarrhenae Rhizoma flavonoids act to inhibit BPH-related inflammation in vivo and in vitro by targeting AA metabolism and interfering with COX and LOX pathways. The identification of mangiferin, neomangiferin and isomangiferin as anti-inflammatory components suggests flavonoids interventions represent a promising therapeutic approach for BPH.

Keywords: Arachidonic acid metabonomics; Cyclooxygenase; Flavonoids; Inflammation; Lipoxygenase.

Publication types

  • Validation Study

MeSH terms

  • Anemarrhena / chemistry*
  • Animals
  • Arachidonate 5-Lipoxygenase / genetics
  • Chromatography, High Pressure Liquid
  • Cyclooxygenase 2 / genetics
  • Disease Models, Animal
  • Drugs, Chinese Herbal / pharmacology
  • Flavonoids / isolation & purification
  • Flavonoids / pharmacology*
  • Humans
  • Inflammation / drug therapy*
  • Male
  • Metabolomics
  • PC-3 Cells
  • Prostatic Hyperplasia / drug therapy*
  • Rats
  • Rats, Sprague-Dawley
  • Rhizome
  • Tandem Mass Spectrometry

Substances

  • Drugs, Chinese Herbal
  • Flavonoids
  • Arachidonate 5-Lipoxygenase
  • Cyclooxygenase 2